Lithium nephrotoxicity revisited

@article{Grnfeld2009LithiumNR,
  title={Lithium nephrotoxicity revisited},
  author={J. Gr{\"u}nfeld and B. Rossier},
  journal={Nature Reviews Nephrology},
  year={2009},
  volume={5},
  pages={270-276}
}
  • J. Grünfeld, B. Rossier
  • Published 2009
  • Medicine
  • Nature Reviews Nephrology
  • Lithium is widely used to treat bipolar disorder. Nephrogenic diabetes insipidus (NDI) is the most common adverse effect of lithium and occurs in up to 40% of patients. Renal lithium toxicity is characterized by increased water and sodium diuresis, which can result in mild dehydration, hyperchloremic metabolic acidosis and renal tubular acidosis. The concentrating defect and natriuretic effect develop within weeks of lithium initiation. After years of lithium exposure, full-blown nephropathy… CONTINUE READING
    221 Citations

    Paper Mentions

    Observational Clinical Trial
    The purpose of this study is to test the hypothesis that the function and/or regulation of urinary aquaporin 2 in hypercholesterolemic humans is affected by standard statin therapy, as… Expand
    ConditionsDiabetes Insipidus, Hypercholesterolemia
    LITHIUM NEPHROTOXICITY
    • 1
    • PDF
    Lithium induce nephropathy; an updated review
    • Highly Influenced
    Nefrotoxicidade por lítio
    • 27
    • PDF
    Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification
    • 11
    • Highly Influenced
    What we need to know about the effect of lithium on the kidney.
    • 27
    Severe hypernatraemia associated with lithium treatment.
    Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
    • 24
    • PDF

    References

    SHOWING 1-10 OF 61 REFERENCES
    Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
    • 102
    • PDF
    Lithium-Induced Nephrogenic Diabetes Insipidus
    • K. Stone
    • Medicine
    • The Journal of the American Board of Family Medicine
    • 1999
    • 57
    • PDF
    Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria.
    • 111
    • PDF
    Lithium-induced nephropathy: Rate of progression and prognostic factors.
    • 175
    • PDF
    Segment-specific ENaC downregulation in kidney of rats with lithium-induced NDI.
    • 65
    • PDF
    Lithium toxicity: a double-edged sword.
    • 41
    • PDF